ORIC · Oric Pharmaceuticals, Inc. · Executive Compensation

$13.78 +1.06 (+8.33%) At close · Oct 20

Russell 2000 member Rebalance outlook locked

Market Cap

$1.32B

103.65M

Volume · Oct 20 2.02M Avg daily vol (3M) 1.49M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$657,500	—	$826,000	$3,634,560	$434,000	$15,104	$5,567,164
Pratik Multani	Chief Medical Officer	$513,333	—	$280,840	$1,226,664	$246,500	$15,104	$2,282,441
Dominic Piscitelli	Chief Financial Officer	$482,917	—	$280,840	$1,226,664	$231,900	$15,104	$2,237,425

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$627,333	—	$776,900	$3,466,878	$396,800	$14,904	$5,282,815
Pratik Multani	Chief Medical Officer	$493,583	—	$274,200	$1,223,604	$227,100	$14,904	$2,233,391
Dominic Piscitelli	Chief Financial Officer	$458,083	—	$274,200	$1,223,604	$210,800	$15,272	$2,181,959

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$596,083	—	$396,000	$1,796,080	$350,200	$14,720	$3,153,083
Pratik Multani	Chief Medical Officer	$476,500	—	$144,000	$651,079	$224,000	$14,720	$1,510,299
Dominic Piscitelli	Chief Financial Officer	$435,584	—	$144,000	$651,079	$204,800	$14,358	$1,449,821

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$572,103	—	$474,000	$2,970,009	$336,110	$13,108	$4,365,330
Dominic Piscitelli	Chief Financial Officer	$418,348	—	$171,825	$1,110,821	$196,623	$21,942	$1,919,559
Pratik Multani	Chief Medical Officer	$458,349	—	$171,825	$1,050,296	$215,424	$13,108	$1,909,002

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$536,278	—	—	$6,092,240	$335,200	$12,206	$6,975,924
Pratik Multani	Chief Medical Officer	$438,352	—	—	$1,958,220	$219,200	$12,206	$2,627,978
Dominic Piscitelli	Chief Financial Officer	$398,518	—	—	$1,958,220	$199,300	$12,206	$2,568,244

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$489,167	—	—	$5,082,831	$300,800	$988	$5,873,786
Pratik Multani	Chief Medical Officer	$416,667	—	—	$1,713,640	$205,000	$621	$2,335,928
Dominic Piscitelli	Chief Financial Officer	$380,833	—	—	$1,002,044	$187,400	$606	$1,570,883

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dominic Piscitelli	Chief Financial Officer	$115,144	—	—	$1,083,150	$38,300	$111	$1,236,705
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$455,833	—	—	—	$194,900	$21,396	$672,129
Pratik Multani	Chief Medical Officer	$398,333	—	—	—	$132,400	$4,423	$535,156

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$290,000	—	—	$1,194,442	$92,800	$57,897	$1,635,139
Pratik Multani	Chief Medical Officer	$112,500	—	—	$324,768	$27,000	$25,876	$490,144
Dominic Piscitelli	Chief Financial Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Mardi C. Dier	Class III director	Appointed	2026-06-18	2026-06-22
Jacob M. Chacko, M.D.	Class III director	Appointed	2026-06-18	2026-06-22

Leadership

Jacob Chacko CEO, Board Member
Jacob M. Chacko, M.D. CEO, Board Member
Dominic Piscitelli CFO
Angie You Board Member
Angie You, Ph.D. Board Member
Continuing Directors Board Member
Lori Kunkel Board Member
Mardi C. Dier Board Member
Richard Heyman Board Member
Steven L. Hoerter Board Member

Key facts CIK 1796280 CUSIP 68622P109 13F (30d) 12 filings 12 filers Visit website Investor relations